Incorporating the [68Ga]Ga-PSMA PET/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance

Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1464-1466. doi: 10.1007/s00259-024-06642-9.

Authors

Levent Kabasakal¹, Ruştu Turkay², Bulent Onal³

Affiliations

¹ Department of Nuclear Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, 34098, Fatih, Istanbul, Turkey. lkabasakal@tsnm.org.
² Department of Radiology, Haseki Training and Research Hospital, Health Sciences University, Ugur Mumcu Mah, Ataturk Bulvarı, No: 54, Sultangazi, Istanbul, Turkey.
³ Department of Urology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, 34098, Fatih, Istanbul, Turkey.

PMID: 38342786
DOI: 10.1007/s00259-024-06642-9

No abstract available

Publication types

Editorial

MeSH terms

Edetic Acid
Gallium Radioisotopes
Humans
Male
Patient Selection
Positron Emission Tomography Computed Tomography*
Prostate-Specific Antigen
Prostatic Neoplasms* / diagnostic imaging
Watchful Waiting

Substances

Prostate-Specific Antigen
Gallium Radioisotopes
Edetic Acid